Clinical Trials
Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.
Skip to
Cystic Fibrosis (cont’d)
Phase
II
Description | CF202: Dosing Study |
---|---|
Sites | Argentina , Canada |
Subjects | 48 |
Status | Complete |
More Information | |
Media Releases |
Phase
II
Description | CF201: Proof of concept - ability to improve FEV1 and quality of life |
---|---|
Sites | Australia |
Subjects | 40 |
Status | Complete |
More Information | |
Media Releases |
* ClinicalTrials.gov is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. ClinicalTrials.gov provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the ClinicalTrials.gov website.
** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.
*** No further clinical development planned in Bronchiectasis